Search

Your search keyword '"Cohen, Kenneth"' showing total 1,291 results

Search Constraints

Start Over You searched for: Author "Cohen, Kenneth" Remove constraint Author: "Cohen, Kenneth"
1,291 results on '"Cohen, Kenneth"'

Search Results

11. MAPK Pathway Inhibitors Augment Treatments for Pediatric Low-Grade Gliomas

12. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

13. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.

14. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

18. Incarceration: Museum research and practice.

19. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

24. Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children’s Oncology Group Study

25. Clinicopathologic Features of Pediatric Oligodendrogliomas

26. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.

27. CTNI-84. PNOC022: A COMBINATION THERAPY TRIAL USING AN ADAPTIVE PLATFORM DESIGN FOR PATIENTS WITH DIFFUSE MIDLINE GLIOMAS (DMGS) AT INITIAL DIAGNOSIS, POST-RADIATION THERAPY AND AT TIME OF PROGRESSION

32. Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

34. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

38. A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma

40. Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600–Mutant Pediatric High-Grade Glioma.

41. Figure S2 from Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

43. Table S3 from A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors

44. Supplementary Figures S1-S3 from BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model

45. Supplementary Table 1 from Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers

47. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908

48. Contemporary Trends and Barriers to Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation During Doac Predominant Era

49. Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial

Catalog

Books, media, physical & digital resources